Advertisement
Thursday, Dec 02, 2021
Outlook.com
Outlook.com

Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos

On Friday, Bharat Biotech announced that it cancelled an MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for supply of its Covid-19 vaccine Covaxin, in Brazil.

Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos
A few weeks earlier, authorities in Brazil launched a probe to determine if the Brazilian government paid a higher price for Covaxin | File Photo
Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos
outlookindia.com
2021-07-24T10:15:12+05:30

Brazil on Saturday announced the suspension of Bharat Biotech’s Covaxin trials on its soil after the Hyderabad-based pharmaceutical firm terminated its pact with its Brazilian partner Precisa Medicamentos amid a controversy over suspected irregularities in the deal.

On Friday, Bharat Biotech announced that it has cancelled an MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for supply of its Covid-19 vaccine Covaxin, in Brazil. The firm signed an MoU with the two South American companies on November 20.

A few weeks earlier, authorities in Brazil launched a probe to determine if the Brazilian government paid a higher price for Covaxin and if there were irregularities in the deal. Bharat Biotech has denied any wrongdoing and stated that the global pricing of the vaccine has been set between USD 15-20 and accordingly, the jab was offered to the Government of Brazil at the rate of USD 15 per dose.

"In the Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil. The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday (23/7), Anvisa,” the Brazilian health regulator, said on Friday.

Precisa Medicamentos was Bharat Biotechs partner in Brazil, providing assistance, guidance and support with regulatory submissions, licensure, distribution, insurance and conduct of phase III clinical trials, among others.

Following the graft allegations, the Brazilian government suspended Covaxin's order temporarily.

(With PTI inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

UN Seeks Release Of Kashmiri Activist Khurram Parvez, Amendment In UAPA

UN Seeks Release Of Kashmiri Activist Khurram Parvez, Amendment In UAPA

The UN has sought probe into civilian killings in Jammu and Kashmir’s Hyderpora and called on the security forces and armed groups to exercise restraint.

Omicron Cases Spike: 21 Countries That Recorded New Covid-19 Variant

Omicron Cases Spike: 21 Countries That Recorded New Covid-19 Variant

South Africa, the first nation where the virus variant was detected, has reported 77 cases of Omicron so far, prompting travel bans across the world.

Man United, IPL Big Boys, Sydney Sixers Enter UAE T20 League

Man United, IPL Big Boys, Sydney Sixers Enter UAE T20 League

Lancer Capital has made its first-ever historic foray into cricket by acquiring a franchise in the UAE T20 league. The ECB has already roped in IPL teams like MI, DC and KRR.

Five Powerful Indian-Americans Rocking Silicon Valley, Parag Agrawal Latest Addition

Five Powerful Indian-Americans Rocking Silicon Valley, Parag Agrawal Latest Addition

As Parag Agrawal becomes the CEO of Twitter, the Indian diaspora's representation in the tech giants of America, especially the companies in Silicon Valley gets a new badge.

Advertisement